www.fdanews.com/articles/188530-boston-scientifics-drug-eluting-stent-receives-fda-approval
![Boston Scientific Logo](https://www.fdanews.com/ext/resources/test/Device_Images3/Boston-Scientific.gif?t=1576639660&width=430)
Boston Scientific’s Drug-Eluting Stent Receives FDA Approval
September 24, 2018
The FDA approved Boston Scientific’s premarket approval application for its Eluvia drug-eluting vascular stent system.
The device is developed to treat peripheral artery disease by using a drug-polymer combination to continually release paclitaxel over one year.
It is designed to stop tissue from regrowing that may become an obstruction for the stented artery.